|
US5836705A
(en)
*
|
1992-07-27 |
1998-11-17 |
Choate; John I. M. |
Keyboard arrangement to maximize typing speed and data entry and to ease transition from a qwerty keyboard
|
|
US5352050A
(en)
*
|
1992-07-27 |
1994-10-04 |
Choate John I M |
Keyboard arrangement to maximize typing speed and ease of transition from a QWERTY keyboard
|
|
US5498088A
(en)
*
|
1992-07-27 |
1996-03-12 |
Choate; John I. M. |
Keyboard arrangement to maximize typing speed and ease of transition from a qwerty keyboard
|
|
DK72793D0
(da)
*
|
1993-06-21 |
1993-06-21 |
Novo Nordisk As |
Nyt produkt
|
|
US5461031A
(en)
*
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
|
US5474978A
(en)
*
|
1994-06-16 |
1995-12-12 |
Eli Lilly And Company |
Insulin analog formulations
|
|
US5547929A
(en)
*
|
1994-09-12 |
1996-08-20 |
Eli Lilly And Company |
Insulin analog formulations
|
|
US5693609A
(en)
*
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
|
YU18596A
(sh)
*
|
1995-03-31 |
1998-07-10 |
Eli Lilly And Company |
Analogne formulacije monomernog insulina
|
|
ATE252913T1
(de)
*
|
1995-06-30 |
2003-11-15 |
Novo Nordisk As |
Vorbeugung einer krankheit mit diabetes charakter
|
|
UA72427C2
(en)
*
|
1996-06-20 |
2005-03-15 |
Novo Nordisk As |
Water-soluble insulin preparation containing mannite, method for manufacturing composition containing soluble insulin or crystalline insulin
|
|
PT921812E
(pt)
*
|
1996-06-20 |
2002-04-29 |
Novo Nordisk As |
Preparacoes de insulina contendo um halogenuro
|
|
ZA984697B
(en)
*
|
1997-06-13 |
1999-12-01 |
Lilly Co Eli |
Stable insulin formulations.
|
|
SV1998000125A
(es)
|
1997-10-24 |
1999-05-24 |
Lilly Co Eli |
Composiciones de insulina insoluble ref. x-11232
|
|
US6531448B1
(en)
|
1997-12-23 |
2003-03-11 |
Eli Lilly And Company |
Insoluble compositions for controlling blood glucose
|
|
EP1044016B1
(en)
*
|
1998-01-09 |
2005-03-16 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
|
US6635617B1
(en)
|
1998-10-16 |
2003-10-21 |
Novo Nordisk A/S |
Insulin preparations for pulmonary delivery containing menthol
|
|
US6211144B1
(en)
|
1998-10-16 |
2001-04-03 |
Novo Nordisk A/S |
Stable concentrated insulin preparations for pulmonary delivery
|
|
PT1121144E
(pt)
*
|
1998-10-16 |
2002-11-29 |
Novo Nordisk As |
Preparados de insulina concentrada estavel para administracao pulmonar
|
|
HUP0103606A3
(en)
*
|
1998-10-16 |
2002-05-28 |
Novo Nordisk As |
Insulin preparations for pulmonary delivery containing menthol
|
|
US6489292B1
(en)
|
1998-11-18 |
2002-12-03 |
Novo Nordisk A/S |
Stable aqueous insulin preparations without phenol and cresol
|
|
EP1131089B1
(en)
*
|
1998-11-18 |
2004-02-18 |
Novo Nordisk A/S |
Stable aqueous insulin preparations without phenol and cresol
|
|
US20040214747A1
(en)
*
|
1999-01-06 |
2004-10-28 |
Dimarchi Richard Dennis |
Method for administering monomeric insulin
|
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
|
US7022674B2
(en)
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
|
AU2001220765A1
(en)
|
2000-01-24 |
2001-07-31 |
Medtronic Minimed, Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
|
WO2002009639A2
(en)
*
|
2000-07-31 |
2002-02-07 |
Bar Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
|
DE10114178A1
(de)
|
2001-03-23 |
2002-10-10 |
Aventis Pharma Gmbh |
Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
|
|
US6737401B2
(en)
|
2001-06-28 |
2004-05-18 |
Metronic Minimed, Inc. |
Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
|
|
RU2202365C2
(ru)
*
|
2001-07-20 |
2003-04-20 |
Институт биоорганической химии им. М.М.Шемякина и Ю.А.Овчинникова РАН |
Способ приготовления быстродействующего раствора инсулина для инъекций
|
|
EP1469827B1
(en)
|
2002-01-09 |
2017-12-27 |
Emisphere Technologies, Inc. |
Polymorphs of sodium 4- (4-chloro-2-hydroxybenzoyl)amino butanoate
|
|
US20030211976A1
(en)
*
|
2002-03-07 |
2003-11-13 |
Andreasen Kasper Huus |
Polyamino acid-based particle insulin formulation
|
|
US20040005999A1
(en)
*
|
2002-03-07 |
2004-01-08 |
Andreasen Kasper Huus |
Polyamino acid-based particle insulin preparation
|
|
DE10227232A1
(de)
*
|
2002-06-18 |
2004-01-15 |
Aventis Pharma Deutschland Gmbh |
Saure Insulinzubereitungen mit verbesserter Stabilität
|
|
US20060258561A1
(en)
*
|
2003-03-13 |
2006-11-16 |
Novo Nordisk A/S |
Novel NPH insulin preparations
|
|
ES2313018T3
(es)
|
2003-06-17 |
2009-03-01 |
Sembiosys Genetics Inc. |
Procedimiento de produccion de insulina en plantas.
|
|
SI1648933T1
(sl)
*
|
2003-07-25 |
2010-01-29 |
Conjuchem Biotechnologies Inc |
Dolgo delujoäś inzulinski derivat in metoda zanj
|
|
WO2005072803A1
(en)
*
|
2004-01-16 |
2005-08-11 |
Biodel, Inc. |
Sublingual drug delivery device
|
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
|
SG153039A1
(en)
|
2004-05-06 |
2009-06-29 |
Emisphere Tech Inc |
Crystalline polymorphic forms of monosodium n-[8- (2hydroxybenzoyl)amino]caprylate
|
|
WO2005117854A2
(en)
*
|
2004-05-14 |
2005-12-15 |
Emisphere Technologies, Inc. |
Aryl ketone compounds and compositions for delivering active agents
|
|
WO2005115341A2
(en)
*
|
2004-05-27 |
2005-12-08 |
Advanced Bionutrition Corporation |
Microparticles for oral delivery
|
|
MX2007000883A
(es)
|
2004-07-19 |
2007-04-02 |
Biocon Ltd |
Conjugados de insulina-oligomero, formulaciones y usos de los mismos.
|
|
AU2005271526B2
(en)
*
|
2004-08-03 |
2011-12-08 |
Emisphere Technologies, Inc. |
Antidiabetic oral insulin-biguanide combination
|
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
|
JP2008509933A
(ja)
*
|
2004-08-13 |
2008-04-03 |
エミスフェアー・テクノロジーズ・インク |
送達剤のマイクロ粒子またはナノ粒子を含む医薬製剤
|
|
HUE048806T2
(hu)
*
|
2004-10-05 |
2020-08-28 |
Novo Nordisk As |
Inzulin kristályos, valamint szolubilizált formáját tartalmazó gyógyászati készítmény
|
|
JP4874989B2
(ja)
|
2004-11-22 |
2012-02-15 |
ノヴォ ノルディスク アー／エス |
可溶性で安定なインスリン含有調合物
|
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
|
JPWO2006093222A1
(ja)
*
|
2005-03-02 |
2008-08-07 |
味の素株式会社 |
インスリンの多量体形成阻害剤
|
|
EP2452687A3
(en)
|
2005-08-29 |
2012-09-05 |
HealOr Ltd. |
Methods and compositions for prevention and treatment of diabetic and aged skin
|
|
AU2006292337B8
(en)
*
|
2005-09-19 |
2013-02-07 |
Emisphere Technologies, Inc. |
Crystalline forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid
|
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
|
US7713929B2
(en)
*
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
|
US20090069216A1
(en)
*
|
2006-02-21 |
2009-03-12 |
Novo Nordisk A/S |
Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof
|
|
CA2649109A1
(en)
|
2006-04-12 |
2007-10-25 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
|
US8927015B2
(en)
|
2006-04-12 |
2015-01-06 |
Emisphere Technologies, Inc. |
Formulations for delivering insulin
|
|
ES2554773T3
(es)
|
2006-10-04 |
2015-12-23 |
Case Western Reserve University |
Insulina y análogos de la insulina resistentes a la fibrilación
|
|
ES2579229T3
(es)
|
2007-03-13 |
2016-08-08 |
Jds Therapeutics, Llc |
Procedimientos y composiciones para la liberación sostenida de cromo
|
|
JP5526018B2
(ja)
*
|
2007-03-21 |
2014-06-18 |
エミスフェアー・テクノロジーズ・インク |
アリルオキシおよびアルキルオキシ安息香酸送達薬剤
|
|
JP2010525033A
(ja)
*
|
2007-04-30 |
2010-07-22 |
ノボ・ノルデイスク・エー／エス |
高濃縮のインスリン溶液及び組成物
|
|
WO2009002867A2
(en)
|
2007-06-26 |
2008-12-31 |
Nutrition 21, Inc. |
Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
|
|
BRPI0818004B8
(pt)
|
2007-10-16 |
2021-05-25 |
Biocon Ltd |
composição farmacêutica sólida administrável por via oral e o processo da mesma.
|
|
WO2009059188A1
(en)
|
2007-11-02 |
2009-05-07 |
Emisphere Technologies, Inc. |
Method of treating vitamin b12 deficiency
|
|
KR20110061552A
(ko)
|
2008-07-31 |
2011-06-09 |
케이스 웨스턴 리저브 유니버시티 |
할로겐 안정화된 인슐린
|
|
WO2010028175A1
(en)
|
2008-09-08 |
2010-03-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulators of aldehyde dehydrogenase activity and methods of use thereof
|
|
EP3228320B1
(de)
|
2008-10-17 |
2019-12-18 |
Sanofi-Aventis Deutschland GmbH |
Kombination von einem insulin und einem glp-1-agonisten
|
|
EP2349279A4
(en)
|
2008-10-28 |
2013-12-25 |
Univ Leland Stanford Junior |
MODIFIERS OF ALDEHYDE DEHYDROGENASE AND METHODS OF USE THEREOF
|
|
US8940690B2
(en)
|
2009-01-28 |
2015-01-27 |
National Institutes Of Health (Nih) |
Synthetic conjugates and uses thereof
|
|
US9050370B2
(en)
|
2009-01-28 |
2015-06-09 |
Smartcells, Inc. |
Conjugate based systems for controlled drug delivery
|
|
US20110293562A1
(en)
|
2009-02-12 |
2011-12-01 |
Proyecto De Biomedicina Cima, S.L. |
Use of cardiotrophin-1 for the treatment of metabolic diseases
|
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
|
WO2010107519A1
(en)
|
2009-03-20 |
2010-09-23 |
Smartcells, Inc. |
Terminally-functionalized conjugates and uses thereof
|
|
EP3202394A1
(de)
|
2009-07-06 |
2017-08-09 |
Sanofi-Aventis Deutschland GmbH |
Wässrige insulinzubereitungen enthaltend methionin
|
|
PT2554183T
(pt)
|
2009-11-13 |
2018-07-09 |
Sanofi Aventis Deutschland |
Composição farmacêutica que compreende um agonista de glp-1, uma insulina e metionina
|
|
PE20121316A1
(es)
|
2009-11-13 |
2012-10-05 |
Sanofi Aventis Deutschland |
Composicion farmaceutica que comprende un agonista de glp-1 y metionina
|
|
JP2013516500A
(ja)
|
2010-01-11 |
2013-05-13 |
ヒールオア・リミテッド |
炎症性疾患および障害を治療するための方法
|
|
KR20130026429A
(ko)
*
|
2010-02-24 |
2013-03-13 |
에미스페어 테크놀로지스, 인코포레이티드 |
경구 ｂ12 치료요법
|
|
US20140148384A1
(en)
|
2010-08-30 |
2014-05-29 |
Sanofi-Aventis Deutschland Gmbh |
Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
|
|
US9309209B2
(en)
|
2010-09-30 |
2016-04-12 |
Solvay Sa |
Derivative of epichlorohydrin of natural origin
|
|
WO2012115641A1
(en)
|
2011-02-23 |
2012-08-30 |
Elona Biotechnologies |
Lis-pro proinsulin compositions and methods of producing lis-pro insulin analogs therefrom
|
|
AU2012223282B2
(en)
|
2011-03-01 |
2017-02-02 |
Nutrition 21, Llc |
Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
|
|
WO2012149106A1
(en)
|
2011-04-29 |
2012-11-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
|
US9821032B2
(en)
|
2011-05-13 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
|
|
CN108079281A
(zh)
|
2011-08-29 |
2018-05-29 |
赛诺菲-安万特德国有限公司 |
用于2型糖尿病患者中的血糖控制的药物组合
|
|
TWI559929B
(en)
|
2011-09-01 |
2016-12-01 |
Sanofi Aventis Deutschland |
Pharmaceutical composition for use in the treatment of a neurodegenerative disease
|
|
AU2012328407A1
(en)
|
2011-10-27 |
2014-05-22 |
Case Western Reserve University |
Ultra-concentrated rapid-acting insulin analogue formulations
|
|
US10159735B2
(en)
*
|
2012-06-26 |
2018-12-25 |
The Curators Of The University Of Missouri |
Photocleavable drug conjugates
|
|
DK2877200T3
(da)
|
2012-07-17 |
2019-08-12 |
Univ Case Western Reserve |
O-bundne carbonhydratmodificerede insulinanaloger
|
|
KR20150082640A
(ko)
|
2012-11-13 |
2015-07-15 |
아도시아 |
치환된 음이온성 화합물을 포함하는 속효성 인슐린 제형
|
|
JP6735561B2
(ja)
|
2012-12-03 |
2020-08-05 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
Ｏ−グリコシル化カルボキシ末端部分（ｃｔｐ）ペプチド系のインスリンおよびインスリン類似体
|
|
MX360420B
(es)
|
2012-12-19 |
2018-10-31 |
Wockhardt Ltd |
Una composicion acuosa estable que comprende insulina humana o un analogo o derivado de la misma.
|
|
MX2015006997A
(es)
|
2012-12-26 |
2015-09-23 |
Wockhardt Ltd |
Composicion farmaceutica.
|
|
KR20150135332A
(ko)
|
2013-03-14 |
2015-12-02 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법
|
|
TW201605489A
(zh)
|
2013-10-25 |
2016-02-16 |
賽諾菲公司 |
賴谷胰島素（ｉｎｓｕｌｉｎ ｇｌｕｌｉｓｉｎｅ）的穩定調配物
|
|
US10124040B2
(en)
|
2014-08-26 |
2018-11-13 |
Merck Sharp & Dohme Corp. |
Method for preparing crystalline insulin or insulin analog compositions
|
|
TWI758239B
(zh)
|
2014-12-12 |
2022-03-21 |
德商賽諾菲阿凡提斯德意志有限公司 |
甘精胰島素/利司那肽固定比率配製劑
|
|
TW201630622A
(zh)
|
2014-12-16 |
2016-09-01 |
美國禮來大藥廠 |
速效胰島素組合物
|
|
TWI748945B
(zh)
|
2015-03-13 |
2021-12-11 |
德商賽諾菲阿凡提斯德意志有限公司 |
第２型糖尿病病患治療
|
|
TW201705975A
(zh)
|
2015-03-18 |
2017-02-16 |
賽諾菲阿凡提斯德意志有限公司 |
第２型糖尿病病患之治療
|
|
JO3749B1
(ar)
|
2015-08-27 |
2021-01-31 |
Lilly Co Eli |
تركيبات إنسولين سريعة المفعول
|
|
AU2017217466A1
(en)
|
2016-02-11 |
2018-08-23 |
Nutrition 21, Llc |
Chromium containing compositions for improving health and fitness
|
|
WO2018222787A1
(en)
|
2017-06-01 |
2018-12-06 |
Eli Lilly And Company |
Rapid-acting insulin compositions
|
|
US11413352B2
(en)
|
2017-12-18 |
2022-08-16 |
Merck, Sharp & Dohme LLC |
Conjugate based systems for controlled insulin delivery
|
|
WO2019125878A1
(en)
|
2017-12-18 |
2019-06-27 |
Merck Sharp & Dohme Corp. |
Conjugate based systems for controlled insulin delivery
|
|
KR20220115927A
(ko)
|
2019-10-25 |
2022-08-19 |
세르카코르 래버러토리즈, 인크. |
지표 화합물, 지표 화합물을 포함하는 장치, 및 이의 제조 및 사용 방법
|
|
KR20220161422A
(ko)
|
2020-03-31 |
2022-12-06 |
프로토머 테크놀로지스 인크. |
비시날 디올에 대한 선택적인 반응을 위한 접합체
|
|
PE20231948A1
(es)
|
2020-11-19 |
2023-12-05 |
Protomer Tech Inc |
Compuestos aromaticos que contienen boro y analogos de insulina
|
|
AR129357A1
(es)
|
2022-05-18 |
2024-08-14 |
Protomer Tech Inc |
Compuestos aromáticos que contienen boro y análogos de insulina relacionados
|